Diagnostics company Cepheid overcharging and undersupplying critical COVID-19 test

MSF called on Cepheid to refrain from profiteering off of the pandemic, by lowering the price of each test to US $5 from the nearly $20 it charges in the world’s poorest countries, in order to ensure much broader access to the test. MSF research shows the tests could be sold at a profit for $5 each.

Read the full press-release here: https://www.msf.org.za/stories-news/press-releases/covid-19-test-maker-cepheid-overcharges-and-undersupplies-who-effort?utm_source=News%20Media&utm_medium=Press_email&utm_campaign=OnlineContentJuly2020

1 Like